These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 15171554)
1. [Expressive level of vascular endothelial growth factor in peripheral blood in patients with pituitary adenomas]. Kong YG; Ren ZY; Su CB; Wang RZ; Xing B Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):164-7. PubMed ID: 15171554 [TBL] [Abstract][Full Text] [Related]
2. Elevated soluble epidermal growth factor receptor level in pituitary adenoma and carcinoma. Kong YG; Ren ZY; Su CB; Wang RZ; Ma WB; Lian W Chin Med Sci J; 2004 Sep; 19(3):199-202. PubMed ID: 15506648 [TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and soluble interleukin-2 receptor (sIL-2R) concentrations in peripheral blood as markers of pituitary tumours. Komorowski J; Jankewicz J; Stepień H Cytobios; 2000; 101(398):151-9. PubMed ID: 10755214 [TBL] [Abstract][Full Text] [Related]
4. Blocking vascular endothelial growth factor-A inhibits the growth of pituitary adenomas and lowers serum prolactin level in a mouse model of multiple endocrine neoplasia type 1. Korsisaari N; Ross J; Wu X; Kowanetz M; Pal N; Hall L; Eastham-Anderson J; Forrest WF; Van Bruggen N; Peale FV; Ferrara N Clin Cancer Res; 2008 Jan; 14(1):249-58. PubMed ID: 18172277 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of tumor angiogenic factors in human pituitary adenomas. Niveiro M; Aranda FI; Peiró G; Alenda C; Picó A Hum Pathol; 2005 Oct; 36(10):1090-5. PubMed ID: 16226108 [TBL] [Abstract][Full Text] [Related]
6. High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies. Poon RT; Lau C; Pang R; Ng KK; Yuen J; Fan ST Ann Surg Oncol; 2007 Jun; 14(6):1835-45. PubMed ID: 17406950 [TBL] [Abstract][Full Text] [Related]
7. Relationship between intratumoral hemorrhage and overexpression of vascular endothelial growth factor (VEGF) in pituitary adenoma. Arita K; Kurisu K; Tominaga A; Sugiyama K; Eguchi K; Hama S; Yoshioka H; Yamasaki F; Kanou Y Hiroshima J Med Sci; 2004 Jun; 53(2):23-7. PubMed ID: 15453394 [TBL] [Abstract][Full Text] [Related]
8. High serum levels of vascular endothelial growth factor after hepatectomy are associated with poor prognosis in hepatocellular carcinoma. Tamesa T; Iizuka N; Mori N; Okada T; Takemoto N; Tangoku A; Oka M Hepatogastroenterology; 2009; 56(93):1122-6. PubMed ID: 19760954 [TBL] [Abstract][Full Text] [Related]
9. Serum vascular endothelial growth factor (VEGF) and VEGF-C levels as tumor markers in patients with cervical carcinoma. Mitsuhashi A; Suzuka K; Yamazawa K; Matsui H; Seki K; Sekiya S Cancer; 2005 Feb; 103(4):724-30. PubMed ID: 15637689 [TBL] [Abstract][Full Text] [Related]
10. Serum levels of angiogenic growth factors in patients with thyroid gland tumors and parathyroid adenoma. Veselý D; Astl J; Matucha P; Sterzl I; Betka J Neuro Endocrinol Lett; 2003 Dec; 24(6):417-9. PubMed ID: 15073567 [TBL] [Abstract][Full Text] [Related]
11. Serum hepatocyte growth factor and vascular endothelial growth factor in children with acute liver failure. Aw MM; Mitry RR; Hughes RD; Dhawan A J Pediatr Gastroenterol Nutr; 2007 Feb; 44(2):224-7. PubMed ID: 17255836 [TBL] [Abstract][Full Text] [Related]
12. The potential clinical relevance of serum vascular endothelial growth factor (VEGF) and VEGF-C in recurrent papillary thyroid carcinoma. Yu XM; Lo CY; Lam AK; Lang BH; Leung P; Luk JM Surgery; 2008 Dec; 144(6):934-40; discussion 940-1. PubMed ID: 19041000 [TBL] [Abstract][Full Text] [Related]
13. Serum VEGF increases in diabetic polyneuropathy, particularly in the neurologically active symptomatic stage. Deguchi T; Hashiguchi T; Horinouchi S; Uto T; Oku H; Kimura K; Makisumi K; Arimura K Diabet Med; 2009 Mar; 26(3):247-52. PubMed ID: 19317819 [TBL] [Abstract][Full Text] [Related]
14. [Dynamic changes of plasma VEGF, SDF-1 and peripheral CD34+ cells in patients with acute myocardial infarction]. Deng ZR; Yang C; Ma AQ; Chen XY; Geng T Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1637-40. PubMed ID: 17121721 [TBL] [Abstract][Full Text] [Related]
15. Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma. Yu XM; Lo CY; Lam AK; Leung P; Luk JM Ann Surg; 2008 Mar; 247(3):483-9. PubMed ID: 18376194 [TBL] [Abstract][Full Text] [Related]
16. Potential prognostic value of circulating levels of vascular endothelial growth factor-A in patients with gastric cancer. Ding S; Lin S; Dong X; Yang X; Qu H; Huang S; Liu W; Zhou L; Liu D In Vivo; 2005; 19(4):793-5. PubMed ID: 15999551 [TBL] [Abstract][Full Text] [Related]
17. Plasma vascular endothelial growth factor as a marker for early vascular damage in hypertension. Tsai WC; Li YH; Huang YY; Lin CC; Chao TH; Chen JH Clin Sci (Lond); 2005 Jul; 109(1):39-43. PubMed ID: 15740459 [TBL] [Abstract][Full Text] [Related]
18. [The protective effect of angiopoietin-1 on early acute lung injury induced by oleic acid in mice]. Guo Q; Huang JA; Jin J; Wang J; Fu JH; Yang XJ Zhonghua Jie He He Hu Xi Za Zhi; 2007 Dec; 30(12):926-31. PubMed ID: 18336770 [TBL] [Abstract][Full Text] [Related]
19. Serum levels of vascular endothelial growth factor elevated in patients with muscular dystrophy. Saito T; Yamamoto Y; Matsumura T; Fujimura H; Shinno S Brain Dev; 2009 Sep; 31(8):612-7. PubMed ID: 18980821 [TBL] [Abstract][Full Text] [Related]
20. [Clinical significance of serum vascular endothelial growth factor and interleukin-6 in multiple myeloma]. Shen JK; Dong LH; Qi H; Zhang GS Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Feb; 30(1):68-71. PubMed ID: 15871192 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]